BridgeMD
New treatment option for Cluster Headache - Episodic and Chronic
Official title Yogabased Movements for Primary Headaches (Migraine and/or Cluster Headache) - YOURHEAD
ClinicalTrials.gov ID: NCT07348783
What this study is testing
- What it's testing
- Brief Summary: Migraine and/or Cluster Headache: Study Overview \ \ Background:\ \ Migraine and cluster headache are two primary headache disorders that significantly impact quality of life and functionality in those affected. According to the WHO's recurring burden of disease reports, migraine is among the neurological conditions responsible for the highest number of years lost due to illness.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Diagnosed chronic migraine and/or cluster (Hortons) headache
- Men and women 18-65 years
- Diagnosed with chronic/high frequency migraine (≥15 headache days/month with at least ≥8 with migraine)
- Diagnosed with chronic cluster head ache (i.e shorter remission than 3 months per year), diagnosed according to ICHD-III criteria.
- Ability to perform yoga based moments and to give consent.
You likely can't join if
- Recent or planned operations during the last 6 weeks
- Drug dependence, alcohol dependence, mental disorders as psychosis, bipolar disorder, anxiety as PTSD etc)
- Parallel enrollment in other clinical trails
- Unmedicated high blood pressure, heart disease as heart failure
- Non Swedish speaking
- Not able to perform low intensity exercise at home or FTF (face to face) - both online or live.
See the full eligibility criteria
- Diagnosed chronic migraine and/or cluster (Hortons) headache
- Men and women 18-65 years
- Diagnosed with chronic/high frequency migraine (≥15 headache days/month with at least ≥8 with migraine)
- Diagnosed with chronic cluster head ache (i.e shorter remission than 3 months per year), diagnosed according to ICHD-III criteria.
- Ability to perform yoga based moments and to give consent.
- Internet connection with computer/ipad/mobile to perform digitally/tele-health instructions
- Willing to use wristwatch for actigraphy
- Willing to leave blood samples in laboratory
- Recent or planned operations during the last 6 weeks
- Drug dependence, alcohol dependence, mental disorders as psychosis, bipolar disorder, anxiety as PTSD etc)
- Parallel enrollment in other clinical trails
- Unmedicated high blood pressure, heart disease as heart failure
- Non Swedish speaking
- Not able to perform low intensity exercise at home or FTF (face to face) - both online or live.
- Participants unsure to participate due to drug addiction or other causes
- Disorientation and not able to inform regarding other serious conditions
The study team makes the final eligibility decision.
Where it's taking place
- Huddinge, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Huddinge, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.